Lower CSF Amyloid Beta Peptides and Higher F2-Isoprostanes in Cognitively Intact Elderly Individuals With Major Depressive Disorder
Objective:Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional antidepressant treatment, especially in the long term. Soluble oligomeric and aggregated forms of amyloid beta peptides, especially amyloid beta 42, impair neuronal and synaptic functi...
Saved in:
| Published in | The American journal of psychiatry Vol. 169; no. 5; pp. 523 - 530 |
|---|---|
| Main Authors | , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Arlington, VA
American Psychiatric Publishing
01.05.2012
American Psychiatric Association |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Objective:Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional antidepressant treatment, especially in the long term. Soluble oligomeric and aggregated forms of amyloid beta peptides, especially amyloid beta 42, impair neuronal and synaptic function. Amyloid beta 42 is the main component of plaques and is implicated in Alzheimer's disease. Amyloid beta peptides also induce a depressive state in rodents and disrupt major neurotransmitter systems linked to depression. The authors assessed whether major depression was associated with CSF levels of amyloid beta, tau protein, and F2-isoprostanes in elderly individuals with major depressive disorder and age-matched nondepressed comparison subjects.
Method:CSF was obtained from 47 cognitively intact volunteers (major depression group, N=28; comparison group, N=19) and analyzed for levels of soluble amyloid beta, total and phosphorylated tau proteins, and isoprostanes.
Results:Amyloid beta 42 levels were significantly lower in the major depression group relative to the comparison group, and amyloid beta 40 levels were lower but only approaching statistical significance. In contrast, isoprostane levels were higher in the major depression group. No differences were observed in total and phosphorylated tau proteins across conditions. Antidepressant use was not associated with differences in amyloid beta 42 levels.
Conclusions:Reduction in CSF levels of amyloid beta 42 may be related to increased brain amyloid beta plaques or decreased soluble amyloid beta production in elderly individuals with major depression relative to nondepressed comparison subjects. These results may have implications for our understanding of the pathophysiology of major depression and for the development of treatment strategies. |
|---|---|
| AbstractList | Objective: Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional antidepressant treatment, especially in the long term. Soluble oligomeric and aggregated forms of amyloid beta peptides, especially amyloid beta 42, impair neuronal and synaptic function. Amyloid beta 42 is the main component of plaques and is implicated in Alzheimer's disease. Amyloid beta peptides also induce a depressive state in rodents and disrupt major neurotransmitter systems linked to depression. The authors assessed whether major depression was associated with CSF levels of amyloid beta, tau protein, and F2-isoprostanes in elderly individuals with major depressive disorder and age-matched nondepressed comparison subjects. Method: CSF was obtained from 47 cognitively intact volunteers (major depression group, N=28; comparison group, N=19) and analyzed for levels of soluble amyloid beta, total and phosphorylated tau proteins, and isoprostanes. Results: Amyloid beta 42 levels were significantly lower in the major depression group relative to the comparison group, and amyloid beta 40 levels were lower but only approaching statistical significance. In contrast, isoprostane levels were higher in the major depression group. No differences were observed in total and phosphorylated tau proteins across conditions. Antidepressant use was not associated with differences in amyloid beta 42 levels. Conclusions: Reduction in CSF levels of amyloid beta 42 may be related to increased brain amyloid beta plaques or decreased soluble amyloid beta production in elderly individuals with major depression relative to nondepressed comparison subjects. These results may have implications for our understanding of the pathophysiology of major depression and for the development of treatment strategies. [PUBLICATION ABSTRACT] Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional antidepressant treatment, especially in the long term. Soluble oligomeric and aggregated forms of amyloid beta peptides, especially amyloid beta 42, impair neuronal and synaptic function. Amyloid beta 42 is the main component of plaques and is implicated in Alzheimer's disease. Amyloid beta peptides also induce a depressive state in rodents and disrupt major neurotransmitter systems linked to depression. The authors assessed whether major depression was associated with CSF levels of amyloid beta, tau protein, and F2-isoprostanes in elderly individuals with major depressive disorder and age-matched nondepressed comparison subjects. Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional antidepressant treatment, especially in the long term. Soluble oligomeric and aggregated forms of amyloid beta peptides, especially amyloid beta 42, impair neuronal and synaptic function. Amyloid beta 42 is the main component of plaques and is implicated in Alzheimer's disease. Amyloid beta peptides also induce a depressive state in rodents and disrupt major neurotransmitter systems linked to depression. The authors assessed whether major depression was associated with CSF levels of amyloid beta, tau protein, and F2-isoprostanes in elderly individuals with major depressive disorder and age-matched nondepressed comparison subjects.OBJECTIVEMajor depressive disorder is common in the elderly, and symptoms are often not responsive to conventional antidepressant treatment, especially in the long term. Soluble oligomeric and aggregated forms of amyloid beta peptides, especially amyloid beta 42, impair neuronal and synaptic function. Amyloid beta 42 is the main component of plaques and is implicated in Alzheimer's disease. Amyloid beta peptides also induce a depressive state in rodents and disrupt major neurotransmitter systems linked to depression. The authors assessed whether major depression was associated with CSF levels of amyloid beta, tau protein, and F2-isoprostanes in elderly individuals with major depressive disorder and age-matched nondepressed comparison subjects.CSF was obtained from 47 cognitively intact volunteers (major depression group, N=28; comparison group, N=19) and analyzed for levels of soluble amyloid beta, total and phosphorylated tau proteins, and isoprostanes.METHODCSF was obtained from 47 cognitively intact volunteers (major depression group, N=28; comparison group, N=19) and analyzed for levels of soluble amyloid beta, total and phosphorylated tau proteins, and isoprostanes.Amyloid beta 42 levels were significantly lower in the major depression group relative to the comparison group, and amyloid beta 40 levels were lower but only approaching statistical significance. In contrast, isoprostane levels were higher in the major depression group. No differences were observed in total and phosphorylated tau proteins across conditions. Antidepressant use was not associated with differences in amyloid beta 42 levels.RESULTSAmyloid beta 42 levels were significantly lower in the major depression group relative to the comparison group, and amyloid beta 40 levels were lower but only approaching statistical significance. In contrast, isoprostane levels were higher in the major depression group. No differences were observed in total and phosphorylated tau proteins across conditions. Antidepressant use was not associated with differences in amyloid beta 42 levels.Reduction in CSF levels of amyloid beta 42 may be related to increased brain amyloid beta plaques or decreased soluble amyloid beta production in elderly individuals with major depression relative to nondepressed comparison subjects. These results may have implications for our understanding of the pathophysiology of major depression and for the development of treatment strategies.CONCLUSIONSReduction in CSF levels of amyloid beta 42 may be related to increased brain amyloid beta plaques or decreased soluble amyloid beta production in elderly individuals with major depression relative to nondepressed comparison subjects. These results may have implications for our understanding of the pathophysiology of major depression and for the development of treatment strategies. Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional antidepressant treatment, especially in the long term. Soluble oligomeric and aggregated forms of amyloid beta peptides, especially amyloid beta 42, impair neuronal and synaptic function. Amyloid beta 42 is the main component of plaques and is implicated in Alzheimer's disease. Amyloid beta peptides also induce a depressive state in rodents and disrupt major neurotransmitter systems linked to depression. The authors assessed whether major depression was associated with CSF levels of amyloid beta, tau protein, and F2-isoprostanes in elderly individuals with major depressive disorder and age-matched nondepressed comparison subjects. CSF was obtained from 47 cognitively intact volunteers (major depression group, N=28; comparison group, N=19) and analyzed for levels of soluble amyloid beta, total and phosphorylated tau proteins, and isoprostanes. Amyloid beta 42 levels were significantly lower in the major depression group relative to the comparison group, and amyloid beta 40 levels were lower but only approaching statistical significance. In contrast, isoprostane levels were higher in the major depression group. No differences were observed in total and phosphorylated tau proteins across conditions. Antidepressant use was not associated with differences in amyloid beta 42 levels. Reduction in CSF levels of amyloid beta 42 may be related to increased brain amyloid beta plaques or decreased soluble amyloid beta production in elderly individuals with major depression relative to nondepressed comparison subjects. These results may have implications for our understanding of the pathophysiology of major depression and for the development of treatment strategies. Objective:Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional antidepressant treatment, especially in the long term. Soluble oligomeric and aggregated forms of amyloid beta peptides, especially amyloid beta 42, impair neuronal and synaptic function. Amyloid beta 42 is the main component of plaques and is implicated in Alzheimer's disease. Amyloid beta peptides also induce a depressive state in rodents and disrupt major neurotransmitter systems linked to depression. The authors assessed whether major depression was associated with CSF levels of amyloid beta, tau protein, and F2-isoprostanes in elderly individuals with major depressive disorder and age-matched nondepressed comparison subjects. Method:CSF was obtained from 47 cognitively intact volunteers (major depression group, N=28; comparison group, N=19) and analyzed for levels of soluble amyloid beta, total and phosphorylated tau proteins, and isoprostanes. Results:Amyloid beta 42 levels were significantly lower in the major depression group relative to the comparison group, and amyloid beta 40 levels were lower but only approaching statistical significance. In contrast, isoprostane levels were higher in the major depression group. No differences were observed in total and phosphorylated tau proteins across conditions. Antidepressant use was not associated with differences in amyloid beta 42 levels. Conclusions:Reduction in CSF levels of amyloid beta 42 may be related to increased brain amyloid beta plaques or decreased soluble amyloid beta production in elderly individuals with major depression relative to nondepressed comparison subjects. These results may have implications for our understanding of the pathophysiology of major depression and for the development of treatment strategies. |
| Author | Nierenberg, Jay Mehta, Pankaj D. Pratico, Domenico Sarreal, Antero S. Zetterberg, Henrik Blennow, Kaj Pomara, Nunzio Sidtis, John J. Bruno, Davide Petkova, Eva Hernando, Raymundo T. Wisniewski, Thomas M. |
| Author_xml | – sequence: 1 givenname: Nunzio surname: Pomara fullname: Pomara, Nunzio email: pomara@nki.rfmh.org – sequence: 2 givenname: Davide surname: Bruno fullname: Bruno, Davide email: pomara@nki.rfmh.org – sequence: 3 givenname: Antero S. surname: Sarreal fullname: Sarreal, Antero S. email: pomara@nki.rfmh.org – sequence: 4 givenname: Raymundo T. surname: Hernando fullname: Hernando, Raymundo T. email: pomara@nki.rfmh.org – sequence: 5 givenname: Jay surname: Nierenberg fullname: Nierenberg, Jay email: pomara@nki.rfmh.org – sequence: 6 givenname: Eva surname: Petkova fullname: Petkova, Eva email: pomara@nki.rfmh.org – sequence: 7 givenname: John J. surname: Sidtis fullname: Sidtis, John J. email: pomara@nki.rfmh.org – sequence: 8 givenname: Thomas M. surname: Wisniewski fullname: Wisniewski, Thomas M. email: pomara@nki.rfmh.org – sequence: 9 givenname: Pankaj D. surname: Mehta fullname: Mehta, Pankaj D. email: pomara@nki.rfmh.org – sequence: 10 givenname: Domenico surname: Pratico fullname: Pratico, Domenico email: pomara@nki.rfmh.org – sequence: 11 givenname: Henrik surname: Zetterberg fullname: Zetterberg, Henrik email: pomara@nki.rfmh.org – sequence: 12 givenname: Kaj surname: Blennow fullname: Blennow, Kaj email: pomara@nki.rfmh.org |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25839883$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22764362$$D View this record in MEDLINE/PubMed https://gup.ub.gu.se/publication/180650$$DView record from Swedish Publication Index |
| BookMark | eNqFkl1v0zAUhiM0xLrBX5gsISRuUvwRO4mEkEa3skpFIAGCO8t1nNZVagc76dRr_jgnawvbLuDGls953mOf4_csOXHemSS5IHhMSC7eqLa1Y7VuxxQTAiFcEMLZk2QEK09zSouTZIQxpmnJ2Y_T5CzGNRwxy-mz5JTSXGRM0FHya-5vTUCTL1N0udk13lbovekU-mzazlYmIuUqdGOXK4CmNJ1F3wYfO-UgZR2a-KWznd2aZodmrlO6Q9dNZcLdsbJbW_Wqiei77Vboo1r7gK5MG0yMIEFXNvoA8PPkaQ2UeXHYz5Nv0-uvk5t0_unDbHI5T1UmSpZqUSul6yLPK6WzjGItiGZ5zvRCZ4xylVWqItwUkNU15SWDgBG5qhg2Ai_YeZLu68Zb0_YL2Qa7UWEnvbJy2bcSQsteRiNJgQXHwL_b8wBvTKWN64JqHsgeZpxdyaXfSsYLwXkOBV4fCgT_szexkxsbtWkaGJ_voySYZrgss1wA-vIRuvZ9cDCOgcKcUVKUQF3cf9Gfpxz_E4BXB0BFrZo6KKdt_MvxgpVFwYB7u-c0_GYMppbadqqzfmjENnCnHGwmB5tJsJkcbCaPNgO5eCQ_3vBfIdsL7_L3Wvyn6jfQROt7 |
| CODEN | AJPSAO |
| CitedBy_id | crossref_primary_10_1176_appi_ajp_2016_16111317 crossref_primary_10_1001_jamapsychiatry_2022_0645 crossref_primary_10_1016_j_lfs_2016_06_027 crossref_primary_10_1097_WNR_0000000000000658 crossref_primary_10_1016_j_jpsychires_2015_07_024 crossref_primary_10_1016_j_jagp_2016_08_018 crossref_primary_10_31887_DCNS_2013_15_4_sarlt crossref_primary_10_3233_JAD_160401 crossref_primary_10_1016_j_nurpra_2020_03_013 crossref_primary_10_1002_gps_4409 crossref_primary_10_1002_gps_4926 crossref_primary_10_1371_journal_pone_0065406 crossref_primary_10_1016_j_jad_2014_06_050 crossref_primary_10_1016_j_psychres_2018_10_012 crossref_primary_10_1016_j_pharmthera_2020_107520 crossref_primary_10_1080_00207454_2020_1744596 crossref_primary_10_1016_j_pscychresns_2017_04_009 crossref_primary_10_3390_antiox11050822 crossref_primary_10_1016_j_jagp_2015_12_003 crossref_primary_10_3390_antiox12040942 crossref_primary_10_1002_gps_4416 crossref_primary_10_1038_s41582_018_0116_6 crossref_primary_10_1016_j_jagp_2014_02_007 crossref_primary_10_1016_j_jad_2021_03_012 crossref_primary_10_3233_JAD_142940 crossref_primary_10_1016_j_jpsychires_2019_01_019 crossref_primary_10_1016_j_yfrne_2019_100783 crossref_primary_10_1038_s41598_017_03836_0 crossref_primary_10_1038_mp_2014_76 crossref_primary_10_1016_j_euroneuro_2016_11_004 crossref_primary_10_3109_00207454_2014_971787 crossref_primary_10_1038_tp_2016_8 crossref_primary_10_1186_s12888_021_03647_8 crossref_primary_10_14336_AD_2024_0286 crossref_primary_10_1111_jgs_13357 crossref_primary_10_1038_s41380_018_0085_6 crossref_primary_10_1016_j_jad_2020_03_166 crossref_primary_10_3233_JAD_210588 crossref_primary_10_1177_0004867414557161 crossref_primary_10_1097_WNR_0000000000000629 crossref_primary_10_1111_ejn_12159 crossref_primary_10_1186_s12888_023_05174_0 crossref_primary_10_1016_j_pnpbp_2015_08_016 crossref_primary_10_1016_j_cca_2019_01_019 crossref_primary_10_1186_1471_244X_13_273 crossref_primary_10_1155_2020_4635163 crossref_primary_10_1016_j_neurobiolaging_2014_05_031 crossref_primary_10_1016_j_jad_2022_07_073 crossref_primary_10_3389_fnagi_2018_00038 crossref_primary_10_3389_fpsyt_2016_00072 crossref_primary_10_1016_j_bbi_2024_05_030 crossref_primary_10_1038_s41398_024_02739_9 crossref_primary_10_1016_j_jagp_2016_05_005 crossref_primary_10_2174_0929867328666210921164816 crossref_primary_10_1002_gps_4215 crossref_primary_10_1016_j_arr_2022_101805 crossref_primary_10_1016_j_dadm_2014_11_002 crossref_primary_10_1002_gps_3879 crossref_primary_10_1097_WAD_0000000000000284 crossref_primary_10_3389_fnins_2024_1305939 crossref_primary_10_1016_j_biopsych_2020_07_025 crossref_primary_10_2217_nmt_13_10 crossref_primary_10_1212_WNL_0000000000001238 crossref_primary_10_1371_journal_pone_0138904 crossref_primary_10_1093_geronb_gbu096 crossref_primary_10_1038_npp_2012_231 crossref_primary_10_1093_arclin_acu045 crossref_primary_10_1097_YCO_0b013e328359edae crossref_primary_10_1016_j_jad_2021_06_030 crossref_primary_10_1016_j_neuropsychologia_2015_11_014 crossref_primary_10_1212_01_wnl_0000436940_78152_05 crossref_primary_10_1002_gps_4339 crossref_primary_10_1016_j_psyneuen_2014_09_025 crossref_primary_10_1186_1741_7015_10_150 crossref_primary_10_1007_s11920_014_0463_y crossref_primary_10_1007_s40473_018_0159_4 crossref_primary_10_3390_ijms232214498 crossref_primary_10_1016_j_jpsychires_2016_07_006 crossref_primary_10_1016_j_jpsychires_2018_02_023 crossref_primary_10_1002_gps_5686 crossref_primary_10_1016_j_bionps_2019_100007 crossref_primary_10_3390_brainsci11101352 crossref_primary_10_1016_j_pnpbp_2012_12_016 crossref_primary_10_1038_s41398_022_02077_8 crossref_primary_10_1007_s00213_016_4473_9 crossref_primary_10_3233_JAD_170001 crossref_primary_10_1016_j_jagp_2018_07_005 crossref_primary_10_1017_S1041610217001880 crossref_primary_10_1038_s41598_021_99794_9 crossref_primary_10_1016_j_jad_2020_09_062 crossref_primary_10_1016_j_neuropsychologia_2015_01_025 crossref_primary_10_1080_14728214_2020_1808621 crossref_primary_10_3233_JAD_170527 crossref_primary_10_1176_appi_ajp_2017_17040442 crossref_primary_10_1002_gps_4489 crossref_primary_10_1016_j_nlm_2017_03_011 crossref_primary_10_1097_PSY_0000000000000030 crossref_primary_10_1016_j_comppsych_2020_152159 crossref_primary_10_1016_j_bbi_2020_07_022 crossref_primary_10_1212_WNL_0000000000004799 crossref_primary_10_3389_fnut_2024_1406656 crossref_primary_10_3233_JAD_180688 crossref_primary_10_1007_s15202_012_0531_2 crossref_primary_10_1016_j_jagp_2018_05_014 crossref_primary_10_3389_fnagi_2021_789698 crossref_primary_10_1016_j_mcn_2020_103555 crossref_primary_10_1038_s41386_021_01072_9 |
| Cites_doi | 10.1097/JGP.0b013e3181aad1fe 10.1016/S1567-5688(02)00045-4 10.1046/j.1440-1614.2001.00967.x 10.1001/archpsyc.63.2.153 10.1007/s11064-005-9029-z 10.1038/npp.2010.216 10.1179/135100003225003393 10.1016/j.biopsych.2006.09.006 10.1002/ana.20730 10.1016/j.neulet.2003.08.011 10.1093/jnen/64.2.139 10.1111/j.1476-5381.2010.00669.x 10.1001/archgenpsychiatry.2011.122 10.1176/appi.ajp.160.2.376 10.1097/00001648-199507000-00006 10.1212/WNL.53.9.1998 10.1126/science.1180962 10.1097/JGP.0b013e3180547091 10.1007/s00018-009-0055-x 10.1038/sj.npp.1300554 10.1038/sj.mp.4002101 10.3233/JAD-2009-1152 10.1016/j.psychres.2008.11.012 10.1001/archneur.57.1.100 10.1016/S0140-6736(06)69113-7 10.1016/j.biopsych.2009.08.024 10.1212/WNL.41.9.1393 10.1001/archneur.60.5.753 10.1016/S1474-4422(06)70355-6 10.1006/nbdi.1996.0003 10.1111/j.2164-0947.1974.tb01606.x 10.1002/gps.1710 10.1097/WAD.0b013e31816c92bf 10.1111/j.1476-5381.2008.00080.x 10.1016/j.exger.2009.08.002 10.1080/1071576021000049890 10.1001/archneur.1985.04060080080019 |
| ContentType | Journal Article |
| Copyright | Copyright © American Psychiatric Association 2012 2015 INIST-CNRS Copyright © American Psychiatric Association |
| Copyright_xml | – notice: Copyright © American Psychiatric Association 2012 – notice: 2015 INIST-CNRS – notice: Copyright © American Psychiatric Association |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM K9. NAPCQ 7X8 5PM ADTPV AOWAS F1U |
| DOI | 10.1176/appi.ajp.2011.11081153 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Göteborgs universitet |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1535-7228 |
| EndPage | 530 |
| ExternalDocumentID | oai_gup_ub_gu_se_180650 PMC3586557 2688100851 22764362 25839883 10_1176_appi_ajp_2011_11081153 10.1176/appi.ajp.2011.11081153 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIA NIH HHS grantid: AG08051 – fundername: NIA NIH HHS grantid: R01 AG020245 – fundername: NIMH NIH HHS grantid: R01 MH080405 – fundername: NINDS NIH HHS grantid: NS073502 – fundername: NINDS NIH HHS grantid: R01 NS073502 – fundername: NIMH NIH HHS grantid: R01 MH-080405 – fundername: NIA NIH HHS grantid: AG20245 – fundername: NIA NIH HHS grantid: P30 AG008051 – fundername: National Institute on Aging : NIA grantid: P30 AG008051 || AG – fundername: National Institute of Neurological Disorders and Stroke : NINDS grantid: R01 NS073502 || NS |
| GroupedDBID | --- --Z -DZ -~X .55 .GJ 08P 0WA 1CY 1HT 1KJ 1QT 23M 2QL 2WC 354 3O- 4.4 41~ 53G 5GY 5RE 6J9 6TJ 7K8 85S 8F7 8R4 8R5 AAAHA AAIKC AAJMC AAJWC AAKAS AAMNW AAQQT AAWTL AAWTO AAYJJ ABIVO ABPPZ ABZEH ACBMB ACGFO ACGOD ACHQT ACNCT ADBBV ADCOW ADZCM AENEX AERZD AETEA AFAZI AFFDN AFFNX AFMIJ AFOSN AGHSJ AGNAY AHJKT AHMBA AI. AIZTS ALMA_UNASSIGNED_HOLDINGS ASUFR BAJDF BAWUL BCR BENPR BKOMP BLC CS3 DIK E3Z EBS EJD EX3 F20 F5P F8P FA8 FJW G0H G8K GOZPB GRPMH HF~ HZ~ J5H L7B LPU LXL LXN MVM N4W N9A NEJ NHB OHT OK1 OVD P-O P2P PEA PQQKQ Q.- Q2X RAY RWL RXW RYA S10 SJN SKT TAE TEORI TR2 TWZ UBC UHB UKR ULE UPT UQL VH1 VVN WH7 WHG WOQ WOW X4V X6Y X7M XJT XOL XSW XZL YCJ YFH YOC YQI YQJ YRY YSK YWH YXB YYQ YZZ ZCA ZGI ZHY ZKB ZRR ZXP ZY1 ~A~ ~G0 ~X8 AAYXX ABDPE ADGHP ADMHG CITATION H13 IQODW CGR CUY CVF ECM EIF NPM K9. NAPCQ 7X8 5PM ADXHL ADTPV AOWAS F1U |
| ID | FETCH-LOGICAL-a4693-c6faacf877dac4420c61c3773cbc4325a4dad15e8ac4cf25934dae67ad30e60b3 |
| ISSN | 0002-953X 1535-7228 |
| IngestDate | Thu Aug 21 06:28:24 EDT 2025 Thu Aug 21 18:19:00 EDT 2025 Fri Jul 11 03:00:03 EDT 2025 Sun Jun 29 15:56:52 EDT 2025 Mon Jul 21 06:03:25 EDT 2025 Wed Apr 02 07:21:12 EDT 2025 Tue Jul 01 01:51:38 EDT 2025 Thu Apr 24 22:54:09 EDT 2025 Wed Jul 24 08:10:56 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | Human Mood disorder Depression Cerebrospinal fluid β Amyloid protein Elderly |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-a4693-c6faacf877dac4420c61c3773cbc4325a4dad15e8ac4cf25934dae67ad30e60b3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/3586557 |
| PMID | 22764362 |
| PQID | 1020532189 |
| PQPubID | 40661 |
| PageCount | 8 |
| ParticipantIDs | swepub_primary_oai_gup_ub_gu_se_180650 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3586557 proquest_miscellaneous_1024099476 proquest_journals_1020532189 pubmed_primary_22764362 pascalfrancis_primary_25839883 crossref_citationtrail_10_1176_appi_ajp_2011_11081153 crossref_primary_10_1176_appi_ajp_2011_11081153 appi_journals_10_1176_appi_ajp_2011_11081153 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2012-05-01 |
| PublicationDateYYYYMMDD | 2012-05-01 |
| PublicationDate_xml | – month: 05 year: 2012 text: 2012-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Arlington, VA |
| PublicationPlace_xml | – name: Arlington, VA – name: United States – name: Washington |
| PublicationTitle | The American journal of psychiatry |
| PublicationTitleAlternate | Am J Psychiatry |
| PublicationYear | 2012 |
| Publisher | American Psychiatric Publishing American Psychiatric Association |
| Publisher_xml | – name: American Psychiatric Publishing – name: American Psychiatric Association |
| References | Sidtis, JJ 2006; 31 Khanzode, SD 2003; 8 Rosengren, L 2010; 176 Tapiola, T 2003; 160 Reynolds, CF 2006; 31 Sweet, RA 2004; 29 Govoni, S 2010; 159 Qiu, WQ 2007; 22 Auerbach, S 2003; 60 Chui, H 2003; 60 Lucchelli, A 2009; 66 Sun, X 2007; 22 Skoog, I 2010; 176 Smith, G 2010; 35 Lopez, OL 2004; 29 Farrer, L 2003; 60 Blusztajn, JK 1996; 3 Csernansky, JG 2009; 18 Gudmundsson, P 2010; 176 Falotico, R 2009; 156 Butters, MA 2008; 22 Griffith, PA 2003; 60 Kokmen, E 1991; 41 Scott, TM 2007; 22 Tuci, P 2010; 159 Palasodkar, R 2003; 8 Willoughby, LM 2006; 31 Arai, H 2003; 160 Dakhale, GN 2003; 8 Kurz, A 2003; 60 Chang, CC 2006; 63 Peskind, ER 2005; 64 Bergethon, P 2007; 22 Eanes, ED 1984; 2 Chapman, M 2002; 3 Beard, CM 1991; 41 Morris, JC 2010; 67 Nishino, S 2009; 326 Friedland, RP 2003; 60 Yaffe, K 2009; 17 Blennow, K 2010; 45 Cuomo, V 2010; 159 Spinner, ML 2006; 59 Reynolds, CF 2009; 17 Cirrito, JR 2009; 326 Catania, C 2009; 14 Zetterberg, H 2006; 5 Lee, JJ 2009; 326 Cupples, LA 2003; 60 Kuller, L 2009; 17 Holtzman, DM 2006; 59 Sotiropoulos, I 2009; 14 Head, D 2010; 67 Winblad, B 1999; 53 Blennow, K 2010; 176 Hanse, E 2010; 45 Mintun, MA 2010; 67 Rosenberg, I 2007; 22 Raichle, ME 2010; 67 Lamere, CA 1996; 3 Zinkowski, R 2003; 160 Pirttilä, T 2003; 160 Kumar, A 2011; 68 Kerkman, D 2003; 160 Mehta, PD 2000; 57 Workman, C 2010; 35 Offord, KP 1991; 41 McCulloch, C 2003; 160 Zetterberg, H 2010; 176 Pomara, N 2006; 31 Mwamburi, DM 2007; 22 Holtzman, DM 2009; 326 Klunk, WE 2006; 59 Schoenberg, BS 1991; 41 Mathis, CA 2006; 59 Govoni, S 2009; 66 Edeki, T 2003; 60 Wisniewski, HM 2000; 57 Lim, MM 2009; 326 Minthon, L 2006; 5 Tsopelas, ND 2008; 22 Pollock, BG 2004; 29 Blennow, K 2006; 368 Hoge, JA 2008; 22 Sadovnick, D 2003; 60 Wahlund, LO 2003; 352 LaRossa, GN 2006; 59 Skoog, I 2007; 15 Pirttilä, T 2000; 57 Lewis, DA 2004; 29 Forsell, Y 1999; 53 Morgese, MG 2010; 159 Holt, D 2010; 35 Bhadela, R 2007; 22 Selkoe, DJ 2007; 22 Roth, AE 2006; 31 Cheng, Y 2009; 156 Zetterberg, H 2003; 352 Siddarth, P 2011; 68 Selkoe, D 1996; 3 Huang, T 2007; 22 Boselli, C 2009; 66 Breen, KC 2009; 14 Buchhave, P 2006; 5 Waern, M 2010; 176 Chang, Y 2009; 17 Buerger, K 2003; 160 Zhao, L 2009; 156 Sersen, EA 2000; 57 Reynolds, CF 2008; 22 DeKosky, ST 2006; 59 Mulsant, BH 2006; 31 Alexopoulos, GS 2006; 60 Ziolko, SK 2008; 22 Go, R 2003; 60 Sheline, YI 2010; 67 Zhou, Y 2010; 35 Butters, MA 2004; 29 Leverenz, JB 2005; 64 Lopez, OL 2009; 17 Brenner, DE 1995; 6 Khanzode, SS 2003; 8 Doraiswamy, PM 2006; 31 Butterfield, DA 2002; 36 Zetterberg, H 2010; 45 Onofri, C 2009; 14 Meltzer, CC 2008; 22 Speck, CE 1995; 6 Mach, RH 2006; 59 Faltraco, F 2003; 160 Thompson, JD 1995; 6 Reding, M 1985; 42 Hansson, O 2006; 5 Ding, T 2009; 156 Gustafson, D 2007; 15 Barrio, J 2011; 68 Snyder, AZ 2010; 67 Schiavone, S 2010; 159 Wong, CW 1984; 2 Mehta, SP 2000; 57 Blennow, K 2007; 15 Farris, W 2005; 64 Ballard, DJ 1991; 41 Haycox, J 1985; 42 Mulsant, BH 2004; 29 Aisen, PS 2000; 57 Fratiglioni, L 1999; 53 Hamilton, RL 2004; 29 Sweet, RA 2009; 17 Green, RC 2003; 60 Kang, JE 2009; 326 Padberg, F 2003; 160 Bateman, RJ 2009; 326 Jorm, AF 2001; 35 Berger, AK 1999; 53 Folstein, M 2007; 22 Gudmundsson, P 2007; 15 DeKosky, ST 2008; 22 Kukull, WA 2003; 60 Du, Y 2006; 63 Mehta, PD 2005; 64 Reynolds, CF 2004; 29 Tian, H 2009; 156 Dew, MA 2009; 17 Shah, AR 2006; 59 Young, J 2009; 17 Ganguli, M 2006; 63 Sousa, N 2009; 14 Teri, L 1995; 6 Mintun, MA 2006; 59 Quaranta, V 1984; 2 Blennow, K 2006; 5 de Leon, MJ 2006; 368 Lopresti, BJ 2008; 22 Munro, C 2010; 35 Elderkin-Thompson, V 2011; 68 Wilkinson, CW 2005; 64 Smyth, LP 2009; 326 Saido, T 1996; 3 McMillan, PJ 2005; 64 DeKosky, ST 2004; 29 Manoukian, V 2011; 68 Blennow, K 2003; 352 Craft, S 2005; 64 Kukull, WA 1995; 6 Duara, R 2003; 60 Marano, C 2010; 35 Barnes, D 2009; 17 Zotti, M 2010; 159 Ma, M 2009; 156 Lanni, C 2009; 66 Fagan, AM 2006; 59 DeBernardis, J 2003; 160 Silva, R 2009; 14 McCormick, WC 1995; 6 Tselepis, AD 2002; 3 Cyrus, T 2009; 156 Wisniewski, T 1996; 3 Wang, L 2007; 22 Pálsson, S 2007; 15 Waern, M 2007; 15 Dence, CS 2006; 59 Cook, DG 2005; 64 Green, PS 2005; 64 Morris, JC 2006; 59 Colaianna, M 2010; 159 Wong, D 2010; 35 Summergrad, P 2007; 22 Bachman, D 2003; 60 Gustafson, D 2010; 176 Bowen, JD 1995; 6 Möller, HJ 2003; 160 Buschke, H 1974; 36 Blass, J 1985; 42 Londos, E 2006; 5 Glenner, GG 1984; 2 Saoji, A 2003; 8 Price, JC 2008; 22 Almeida, OFX 2009; 14 Pratico, D 2009; 156 Dodge, HH 2006; 63 Trabace, L 2010; 159 Ratcliff, GG 2006; 63 Goernitz, A 2003; 160 Larson, EB 1995; 6 Hampel, H 2003; 160 Fujiki, N 2009; 326 Backman, L 1999; 53 Becker, JT 2009; 17 Wang, S 2010; 67 Kepe, V 2011; 68 Mehta, PD 2006; 31 Dong, H 2009; 18 Pollock, BG 2006; 31 Zetterberg, H 2006; 368 Chandra, V 1991; 41 Klunk, WE 2008; 22 Mathis, CA 2008; 22 Pfanschmidt, ML 1995; 6 Yamaguchi, H 1996; 3 Lyketsos, C 2010; 35 Rapoport, SI 2003; 160 Rosengren, L 2007; 15 Small, G 2011; 68 Lee, SY 2006; 59 Kulstad, JJ 2005; 64 Teipel, SJ 2003; 160 B20 B21 B22 B23 B24 B25 B26 B27 B28 B29 Goodglass H (B36) 1972 B30 B31 B10 B32 B11 B33 B34 B13 B14 B15 B37 B16 B38 B17 B39 B18 B19 B1 B2 B3 B4 B5 B6 B7 B8 B9 Glenner GG (B12) 1984; 2 B40 17096467 - Int J Geriatr Psychiatry. 2007 Jun;22(6):536-42 19833321 - Biol Psychiatry. 2010 Mar 15;67(6):584-7 19584430 - J Alzheimers Dis. 2009;18(2):459-69 14615052 - Neurosci Lett. 2003 Nov 27;352(1):67-9 10634455 - Arch Neurol. 2000 Jan;57(1):100-5 1891088 - Neurology. 1991 Sep;41(9):1393-7 17157096 - Biol Psychiatry. 2006 Dec 15;60(12):1304-5 16488378 - Lancet Neurol. 2006 Mar;5(3):228-34 19220291 - Br J Pharmacol. 2009 Mar;156(5):774-85 16583267 - Neurochem Res. 2006 Mar;31(3):341-9 19521663 - Cell Mol Life Sci. 2009 Sep;66(18):2985-3008 9173910 - Neurobiol Dis. 1996 Feb;3(1):16-32 20218978 - Br J Pharmacol. 2010 Apr;159(8):1704-15 12607822 - Free Radic Res. 2002 Dec;36(12):1307-13 19779148 - Science. 2009 Nov 13;326(5955):1005-7 15751228 - J Neuropathol Exp Neurol. 2005 Feb;64(2):139-46 4026634 - Arch Neurol. 1985 Sep;42(9):894-6 15354182 - Neuropsychopharmacology. 2004 Dec;29(12):2242-50 16461857 - Arch Gen Psychiatry. 2006 Feb;63(2):153-60 6242724 - Appl Pathol. 1984;2(6):357-69 17912249 - Mol Psychiatry. 2009 Jan;14(1):95-105 17911361 - Am J Geriatr Psychiatry. 2007 Oct;15(10):832-8 12562590 - Am J Psychiatry. 2003 Feb;160(2):376-9 12756140 - Arch Neurol. 2003 May;60(5):753-9 16372280 - Ann Neurol. 2006 Mar;59(3):512-9 12573364 - Atheroscler Suppl. 2002 Dec;3(4):57-68 7548342 - Epidemiology. 1995 Jul;6(4):366-9 11990888 - Aust N Z J Psychiatry. 2001 Dec;35(6):776-81 19634208 - Am J Geriatr Psychiatry. 2009 Aug;17(8):653-63 19698775 - Exp Gerontol. 2010 Jan;45(1):23-9 20132991 - Psychiatry Res. 2010 Apr 30;176(2-3):174-8 14980069 - Redox Rep. 2003;8(6):365-70 16876668 - Lancet. 2006 Jul 29;368(9533):387-403 22065530 - Arch Gen Psychiatry. 2011 Nov;68(11):1143-50 10599771 - Neurology. 1999 Dec 10;53(9):1998-2002 18580591 - Alzheimer Dis Assoc Disord. 2008 Jul-Sep;22(3):261-8 |
| References_xml | – volume: 22 start-page: 261 year: 2008 end-page: 268 article-title: Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B publication-title: Alzheimer Dis Assoc Disord – volume: 68 start-page: 1143 year: 2011 end-page: 1150 article-title: Protein binding in patients with late-life depression publication-title: Arch Gen Psychiatry – volume: 57 start-page: 100 year: 2000 end-page: 105 article-title: Plasma and cerebrospinal fluid levels of amyloid beta proteins 1–40 and 1–42 in Alzheimer disease publication-title: Arch Neurol – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 15 start-page: 832 year: 2007 end-page: 838 article-title: The relationship between cerebrospinal fluid biomarkers and depression in elderly women publication-title: Am J Geriatr Psychiatry – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 22 start-page: 261 year: 2008 end-page: 268 article-title: Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B publication-title: Alzheimer Dis Assoc Disord – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 15 start-page: 832 year: 2007 end-page: 838 article-title: The relationship between cerebrospinal fluid biomarkers and depression in elderly women publication-title: Am J Geriatr Psychiatry – volume: 3 start-page: 16 year: 1996 end-page: 32 article-title: Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation publication-title: Neurobiol Dis – volume: 59 start-page: 512 year: 2006 end-page: 519 article-title: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans publication-title: Ann Neurol – volume: 3 start-page: 16 year: 1996 end-page: 32 article-title: Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation publication-title: Neurobiol Dis – volume: 42 start-page: 894 year: 1985 end-page: 896 article-title: Depression in patients referred to a dementia clinic: a three-year prospective study publication-title: Arch Neurology – volume: 31 start-page: 341 year: 2006 end-page: 349 article-title: Elevation in plasma Abeta42 in geriatric depression: a pilot study publication-title: Neurochem Res – volume: 14 start-page: 95 year: 2009 end-page: 105 article-title: The amyloidogenic potential and behavioral correlates of stress publication-title: Mol Psychiatry – volume: 2 start-page: 357 year: 1984 end-page: 369 article-title: The amyloid deposits in Alzheimer's disease: their nature and pathogenesis publication-title: Appl Pathol – volume: 22 start-page: 536 year: 2007 end-page: 542 article-title: Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly publication-title: Int J Geriatr Psychiatry – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 352 start-page: 67 year: 2003 end-page: 69 article-title: Cerebrospinal fluid markers for prediction of Alzheimer's disease publication-title: Neurosci Lett – volume: 22 start-page: 261 year: 2008 end-page: 268 article-title: Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B publication-title: Alzheimer Dis Assoc Disord – volume: 17 start-page: 653 year: 2009 end-page: 656 article-title: Depressed mood is not a risk factor for incident dementia in a community-based cohort publication-title: Am J Geriatr Psychiatry – volume: 41 start-page: 1393 year: 1991 end-page: 1397 article-title: Clinical risk factors for Alzheimer's disease: a population-based case-control study publication-title: Neurology – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 6 start-page: 366 year: 1995 end-page: 369 article-title: History of depression as a risk factor for Alzheimer's disease publication-title: Epidemiology – volume: 53 start-page: 1998 year: 1999 end-page: 2002 article-title: The occurrence of depressive symptoms in the preclinical phase of AD publication-title: Neurology – volume: 45 start-page: 23 year: 2010 end-page: 29 article-title: Amyloid β and APP as biomarkers for Alzheimer's disease publication-title: Exp Gerontol – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 29 start-page: 2242 year: 2004 end-page: 2250 article-title: Neuropathologic correlates of late-onset major depression publication-title: Neuropsychopharmacology – volume: 59 start-page: 512 year: 2006 end-page: 519 article-title: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans publication-title: Ann Neurol – volume: 63 start-page: 153 year: 2006 end-page: 160 article-title: Depressive symptoms and cognitive decline in late life: a prospective epidemiological study publication-title: Arch Gen Psychiatry – volume: 22 start-page: 261 year: 2008 end-page: 268 article-title: Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B publication-title: Alzheimer Dis Assoc Disord – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 326 start-page: 1005 year: 2009 end-page: 1007 article-title: Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle publication-title: Science – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 176 start-page: 174 year: 2010 end-page: 178 article-title: Is there a CSF biomarker profile related to depression in elderly women? publication-title: Psychiatry Res – volume: 67 start-page: 584 year: 2010 end-page: 587 article-title: Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly publication-title: Biol Psychiatry – volume: 59 start-page: 512 year: 2006 end-page: 519 article-title: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans publication-title: Ann Neurol – volume: 64 start-page: 139 year: 2005 end-page: 146 article-title: Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque publication-title: J Neuropathol Exp Neurol – volume: 22 start-page: 261 year: 2008 end-page: 268 article-title: Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B publication-title: Alzheimer Dis Assoc Disord – volume: 53 start-page: 1998 year: 1999 end-page: 2002 article-title: The occurrence of depressive symptoms in the preclinical phase of AD publication-title: Neurology – volume: 67 start-page: 584 year: 2010 end-page: 587 article-title: Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly publication-title: Biol Psychiatry – volume: 36 start-page: 1307 year: 2002 end-page: 1313 article-title: Amyloid beta-peptide (1–42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain: a review publication-title: Free Radic Res – volume: 17 start-page: 653 year: 2009 end-page: 656 article-title: Depressed mood is not a risk factor for incident dementia in a community-based cohort publication-title: Am J Geriatr Psychiatry – volume: 17 start-page: 653 year: 2009 end-page: 656 article-title: Depressed mood is not a risk factor for incident dementia in a community-based cohort publication-title: Am J Geriatr Psychiatry – volume: 45 start-page: 23 year: 2010 end-page: 29 article-title: Amyloid β and APP as biomarkers for Alzheimer's disease publication-title: Exp Gerontol – volume: 22 start-page: 536 year: 2007 end-page: 542 article-title: Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly publication-title: Int J Geriatr Psychiatry – volume: 67 start-page: 584 year: 2010 end-page: 587 article-title: Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly publication-title: Biol Psychiatry – volume: 156 start-page: 774 year: 2009 end-page: 785 article-title: Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor publication-title: Br J Clin Pharmacol – volume: 59 start-page: 512 year: 2006 end-page: 519 article-title: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans publication-title: Ann Neurol – volume: 59 start-page: 512 year: 2006 end-page: 519 article-title: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans publication-title: Ann Neurol – volume: 64 start-page: 139 year: 2005 end-page: 146 article-title: Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque publication-title: J Neuropathol Exp Neurol – volume: 59 start-page: 512 year: 2006 end-page: 519 article-title: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans publication-title: Ann Neurol – volume: 31 start-page: 341 year: 2006 end-page: 349 article-title: Elevation in plasma Abeta42 in geriatric depression: a pilot study publication-title: Neurochem Res – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 159 start-page: 1704 year: 2010 end-page: 1715 article-title: Soluble beta amyloid(1–42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? publication-title: Br J Psychopharmacol – volume: 156 start-page: 774 year: 2009 end-page: 785 article-title: Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor publication-title: Br J Clin Pharmacol – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 22 start-page: 261 year: 2008 end-page: 268 article-title: Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B publication-title: Alzheimer Dis Assoc Disord – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 35 start-page: S78 year: 2010 end-page: S187 article-title: Cortical beta-amyloid deposition in late-life depression publication-title: Neuropsychopharmacology – volume: 63 start-page: 153 year: 2006 end-page: 160 article-title: Depressive symptoms and cognitive decline in late life: a prospective epidemiological study publication-title: Arch Gen Psychiatry – volume: 5 start-page: 228 year: 2006 end-page: 234 article-title: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study publication-title: Lancet Neurol – volume: 2 start-page: 357 year: 1984 end-page: 369 article-title: The amyloid deposits in Alzheimer's disease: their nature and pathogenesis publication-title: Appl Pathol – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 66 start-page: 2985 year: 2009 end-page: 3008 article-title: Depression and antidepressants: molecular and cellular aspects publication-title: Cell Mol Life Sci – volume: 36 start-page: 721 year: 1974 end-page: 729 article-title: Retrieval in human learning publication-title: Trans NY Acad Sci – volume: 8 start-page: 365 year: 2003 end-page: 370 article-title: Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors publication-title: Redox Rep – volume: 31 start-page: 341 year: 2006 end-page: 349 article-title: Elevation in plasma Abeta42 in geriatric depression: a pilot study publication-title: Neurochem Res – volume: 14 start-page: 95 year: 2009 end-page: 105 article-title: The amyloidogenic potential and behavioral correlates of stress publication-title: Mol Psychiatry – volume: 22 start-page: 261 year: 2008 end-page: 268 article-title: Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B publication-title: Alzheimer Dis Assoc Disord – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 2 start-page: 357 year: 1984 end-page: 369 article-title: The amyloid deposits in Alzheimer's disease: their nature and pathogenesis publication-title: Appl Pathol – volume: 22 start-page: 536 year: 2007 end-page: 542 article-title: Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly publication-title: Int J Geriatr Psychiatry – volume: 17 start-page: 653 year: 2009 end-page: 656 article-title: Depressed mood is not a risk factor for incident dementia in a community-based cohort publication-title: Am J Geriatr Psychiatry – volume: 29 start-page: 2242 year: 2004 end-page: 2250 article-title: Neuropathologic correlates of late-onset major depression publication-title: Neuropsychopharmacology – volume: 57 start-page: 100 year: 2000 end-page: 105 article-title: Plasma and cerebrospinal fluid levels of amyloid beta proteins 1–40 and 1–42 in Alzheimer disease publication-title: Arch Neurol – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 45 start-page: 23 year: 2010 end-page: 29 article-title: Amyloid β and APP as biomarkers for Alzheimer's disease publication-title: Exp Gerontol – volume: 59 start-page: 512 year: 2006 end-page: 519 article-title: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans publication-title: Ann Neurol – volume: 326 start-page: 1005 year: 2009 end-page: 1007 article-title: Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle publication-title: Science – volume: 66 start-page: 2985 year: 2009 end-page: 3008 article-title: Depression and antidepressants: molecular and cellular aspects publication-title: Cell Mol Life Sci – volume: 64 start-page: 139 year: 2005 end-page: 146 article-title: Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque publication-title: J Neuropathol Exp Neurol – volume: 64 start-page: 139 year: 2005 end-page: 146 article-title: Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque publication-title: J Neuropathol Exp Neurol – volume: 59 start-page: 512 year: 2006 end-page: 519 article-title: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans publication-title: Ann Neurol – volume: 57 start-page: 100 year: 2000 end-page: 105 article-title: Plasma and cerebrospinal fluid levels of amyloid beta proteins 1–40 and 1–42 in Alzheimer disease publication-title: Arch Neurol – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 22 start-page: 261 year: 2008 end-page: 268 article-title: Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B publication-title: Alzheimer Dis Assoc Disord – volume: 42 start-page: 894 year: 1985 end-page: 896 article-title: Depression in patients referred to a dementia clinic: a three-year prospective study publication-title: Arch Neurology – volume: 31 start-page: 341 year: 2006 end-page: 349 article-title: Elevation in plasma Abeta42 in geriatric depression: a pilot study publication-title: Neurochem Res – volume: 17 start-page: 653 year: 2009 end-page: 656 article-title: Depressed mood is not a risk factor for incident dementia in a community-based cohort publication-title: Am J Geriatr Psychiatry – volume: 6 start-page: 366 year: 1995 end-page: 369 article-title: History of depression as a risk factor for Alzheimer's disease publication-title: Epidemiology – volume: 41 start-page: 1393 year: 1991 end-page: 1397 article-title: Clinical risk factors for Alzheimer's disease: a population-based case-control study publication-title: Neurology – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 5 start-page: 228 year: 2006 end-page: 234 article-title: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study publication-title: Lancet Neurol – volume: 68 start-page: 1143 year: 2011 end-page: 1150 article-title: Protein binding in patients with late-life depression publication-title: Arch Gen Psychiatry – volume: 18 start-page: 459 year: 2009 end-page: 469 article-title: Effects of stress and stress hormones on amyloid-beta protein and plaque deposition publication-title: J Alzheimers Dis – volume: 29 start-page: 2242 year: 2004 end-page: 2250 article-title: Neuropathologic correlates of late-onset major depression publication-title: Neuropsychopharmacology – volume: 64 start-page: 139 year: 2005 end-page: 146 article-title: Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque publication-title: J Neuropathol Exp Neurol – volume: 31 start-page: 341 year: 2006 end-page: 349 article-title: Elevation in plasma Abeta42 in geriatric depression: a pilot study publication-title: Neurochem Res – volume: 29 start-page: 2242 year: 2004 end-page: 2250 article-title: Neuropathologic correlates of late-onset major depression publication-title: Neuropsychopharmacology – volume: 15 start-page: 832 year: 2007 end-page: 838 article-title: The relationship between cerebrospinal fluid biomarkers and depression in elderly women publication-title: Am J Geriatr Psychiatry – volume: 5 start-page: 228 year: 2006 end-page: 234 article-title: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study publication-title: Lancet Neurol – volume: 22 start-page: 261 year: 2008 end-page: 268 article-title: Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B publication-title: Alzheimer Dis Assoc Disord – volume: 68 start-page: 1143 year: 2011 end-page: 1150 article-title: Protein binding in patients with late-life depression publication-title: Arch Gen Psychiatry – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 67 start-page: 584 year: 2010 end-page: 587 article-title: Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly publication-title: Biol Psychiatry – volume: 22 start-page: 536 year: 2007 end-page: 542 article-title: Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly publication-title: Int J Geriatr Psychiatry – volume: 64 start-page: 139 year: 2005 end-page: 146 article-title: Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque publication-title: J Neuropathol Exp Neurol – volume: 29 start-page: 2242 year: 2004 end-page: 2250 article-title: Neuropathologic correlates of late-onset major depression publication-title: Neuropsychopharmacology – volume: 59 start-page: 512 year: 2006 end-page: 519 article-title: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans publication-title: Ann Neurol – volume: 22 start-page: 536 year: 2007 end-page: 542 article-title: Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly publication-title: Int J Geriatr Psychiatry – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 35 start-page: S78 year: 2010 end-page: S187 article-title: Cortical beta-amyloid deposition in late-life depression publication-title: Neuropsychopharmacology – volume: 41 start-page: 1393 year: 1991 end-page: 1397 article-title: Clinical risk factors for Alzheimer's disease: a population-based case-control study publication-title: Neurology – volume: 17 start-page: 653 year: 2009 end-page: 656 article-title: Depressed mood is not a risk factor for incident dementia in a community-based cohort publication-title: Am J Geriatr Psychiatry – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 29 start-page: 2242 year: 2004 end-page: 2250 article-title: Neuropathologic correlates of late-onset major depression publication-title: Neuropsychopharmacology – volume: 17 start-page: 653 year: 2009 end-page: 656 article-title: Depressed mood is not a risk factor for incident dementia in a community-based cohort publication-title: Am J Geriatr Psychiatry – volume: 31 start-page: 341 year: 2006 end-page: 349 article-title: Elevation in plasma Abeta42 in geriatric depression: a pilot study publication-title: Neurochem Res – volume: 35 start-page: S78 year: 2010 end-page: S187 article-title: Cortical beta-amyloid deposition in late-life depression publication-title: Neuropsychopharmacology – volume: 63 start-page: 153 year: 2006 end-page: 160 article-title: Depressive symptoms and cognitive decline in late life: a prospective epidemiological study publication-title: Arch Gen Psychiatry – volume: 326 start-page: 1005 year: 2009 end-page: 1007 article-title: Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle publication-title: Science – volume: 14 start-page: 95 year: 2009 end-page: 105 article-title: The amyloidogenic potential and behavioral correlates of stress publication-title: Mol Psychiatry – volume: 156 start-page: 774 year: 2009 end-page: 785 article-title: Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor publication-title: Br J Clin Pharmacol – volume: 35 start-page: S78 year: 2010 end-page: S187 article-title: Cortical beta-amyloid deposition in late-life depression publication-title: Neuropsychopharmacology – volume: 15 start-page: 832 year: 2007 end-page: 838 article-title: The relationship between cerebrospinal fluid biomarkers and depression in elderly women publication-title: Am J Geriatr Psychiatry – volume: 53 start-page: 1998 year: 1999 end-page: 2002 article-title: The occurrence of depressive symptoms in the preclinical phase of AD publication-title: Neurology – volume: 6 start-page: 366 year: 1995 end-page: 369 article-title: History of depression as a risk factor for Alzheimer's disease publication-title: Epidemiology – volume: 14 start-page: 95 year: 2009 end-page: 105 article-title: The amyloidogenic potential and behavioral correlates of stress publication-title: Mol Psychiatry – volume: 14 start-page: 95 year: 2009 end-page: 105 article-title: The amyloidogenic potential and behavioral correlates of stress publication-title: Mol Psychiatry – volume: 35 start-page: S78 year: 2010 end-page: S187 article-title: Cortical beta-amyloid deposition in late-life depression publication-title: Neuropsychopharmacology – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 6 start-page: 366 year: 1995 end-page: 369 article-title: History of depression as a risk factor for Alzheimer's disease publication-title: Epidemiology – volume: 14 start-page: 95 year: 2009 end-page: 105 article-title: The amyloidogenic potential and behavioral correlates of stress publication-title: Mol Psychiatry – volume: 35 start-page: S78 year: 2010 end-page: S187 article-title: Cortical beta-amyloid deposition in late-life depression publication-title: Neuropsychopharmacology – volume: 156 start-page: 774 year: 2009 end-page: 785 article-title: Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor publication-title: Br J Clin Pharmacol – volume: 22 start-page: 261 year: 2008 end-page: 268 article-title: Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B publication-title: Alzheimer Dis Assoc Disord – volume: 326 start-page: 1005 year: 2009 end-page: 1007 article-title: Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle publication-title: Science – volume: 176 start-page: 174 year: 2010 end-page: 178 article-title: Is there a CSF biomarker profile related to depression in elderly women? publication-title: Psychiatry Res – volume: 59 start-page: 512 year: 2006 end-page: 519 article-title: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans publication-title: Ann Neurol – volume: 64 start-page: 139 year: 2005 end-page: 146 article-title: Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque publication-title: J Neuropathol Exp Neurol – volume: 15 start-page: 832 year: 2007 end-page: 838 article-title: The relationship between cerebrospinal fluid biomarkers and depression in elderly women publication-title: Am J Geriatr Psychiatry – volume: 8 start-page: 365 year: 2003 end-page: 370 article-title: Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors publication-title: Redox Rep – volume: 3 start-page: 57 year: 2002 end-page: 68 article-title: Inflammation, bioactive lipids and atherosclerosis: potential roles of lipoprotein-associated phospholipase A2 platelet activating factor-acethylhydrolase publication-title: Atheroscler Suppl – volume: 326 start-page: 1005 year: 2009 end-page: 1007 article-title: Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle publication-title: Science – volume: 29 start-page: 2242 year: 2004 end-page: 2250 article-title: Neuropathologic correlates of late-onset major depression publication-title: Neuropsychopharmacology – volume: 352 start-page: 67 year: 2003 end-page: 69 article-title: Cerebrospinal fluid markers for prediction of Alzheimer's disease publication-title: Neurosci Lett – volume: 159 start-page: 1704 year: 2010 end-page: 1715 article-title: Soluble beta amyloid(1–42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? publication-title: Br J Psychopharmacol – volume: 29 start-page: 2242 year: 2004 end-page: 2250 article-title: Neuropathologic correlates of late-onset major depression publication-title: Neuropsychopharmacology – volume: 3 start-page: 57 year: 2002 end-page: 68 article-title: Inflammation, bioactive lipids and atherosclerosis: potential roles of lipoprotein-associated phospholipase A2 platelet activating factor-acethylhydrolase publication-title: Atheroscler Suppl – volume: 326 start-page: 1005 year: 2009 end-page: 1007 article-title: Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle publication-title: Science – volume: 63 start-page: 153 year: 2006 end-page: 160 article-title: Depressive symptoms and cognitive decline in late life: a prospective epidemiological study publication-title: Arch Gen Psychiatry – volume: 6 start-page: 366 year: 1995 end-page: 369 article-title: History of depression as a risk factor for Alzheimer's disease publication-title: Epidemiology – volume: 64 start-page: 139 year: 2005 end-page: 146 article-title: Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque publication-title: J Neuropathol Exp Neurol – volume: 156 start-page: 774 year: 2009 end-page: 785 article-title: Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor publication-title: Br J Clin Pharmacol – volume: 6 start-page: 366 year: 1995 end-page: 369 article-title: History of depression as a risk factor for Alzheimer's disease publication-title: Epidemiology – volume: 22 start-page: 536 year: 2007 end-page: 542 article-title: Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly publication-title: Int J Geriatr Psychiatry – volume: 17 start-page: 653 year: 2009 end-page: 656 article-title: Depressed mood is not a risk factor for incident dementia in a community-based cohort publication-title: Am J Geriatr Psychiatry – volume: 159 start-page: 1704 year: 2010 end-page: 1715 article-title: Soluble beta amyloid(1–42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? publication-title: Br J Psychopharmacol – volume: 156 start-page: 774 year: 2009 end-page: 785 article-title: Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor publication-title: Br J Clin Pharmacol – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 3 start-page: 16 year: 1996 end-page: 32 article-title: Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation publication-title: Neurobiol Dis – volume: 41 start-page: 1393 year: 1991 end-page: 1397 article-title: Clinical risk factors for Alzheimer's disease: a population-based case-control study publication-title: Neurology – volume: 66 start-page: 2985 year: 2009 end-page: 3008 article-title: Depression and antidepressants: molecular and cellular aspects publication-title: Cell Mol Life Sci – volume: 59 start-page: 512 year: 2006 end-page: 519 article-title: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans publication-title: Ann Neurol – volume: 6 start-page: 366 year: 1995 end-page: 369 article-title: History of depression as a risk factor for Alzheimer's disease publication-title: Epidemiology – volume: 3 start-page: 16 year: 1996 end-page: 32 article-title: Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation publication-title: Neurobiol Dis – volume: 68 start-page: 1143 year: 2011 end-page: 1150 article-title: Protein binding in patients with late-life depression publication-title: Arch Gen Psychiatry – volume: 66 start-page: 2985 year: 2009 end-page: 3008 article-title: Depression and antidepressants: molecular and cellular aspects publication-title: Cell Mol Life Sci – volume: 53 start-page: 1998 year: 1999 end-page: 2002 article-title: The occurrence of depressive symptoms in the preclinical phase of AD publication-title: Neurology – volume: 22 start-page: 536 year: 2007 end-page: 542 article-title: Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly publication-title: Int J Geriatr Psychiatry – volume: 156 start-page: 774 year: 2009 end-page: 785 article-title: Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor publication-title: Br J Clin Pharmacol – volume: 29 start-page: 2242 year: 2004 end-page: 2250 article-title: Neuropathologic correlates of late-onset major depression publication-title: Neuropsychopharmacology – volume: 159 start-page: 1704 year: 2010 end-page: 1715 article-title: Soluble beta amyloid(1–42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? publication-title: Br J Psychopharmacol – volume: 15 start-page: 832 year: 2007 end-page: 838 article-title: The relationship between cerebrospinal fluid biomarkers and depression in elderly women publication-title: Am J Geriatr Psychiatry – volume: 64 start-page: 139 year: 2005 end-page: 146 article-title: Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque publication-title: J Neuropathol Exp Neurol – volume: 35 start-page: S78 year: 2010 end-page: S187 article-title: Cortical beta-amyloid deposition in late-life depression publication-title: Neuropsychopharmacology – volume: 326 start-page: 1005 year: 2009 end-page: 1007 article-title: Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle publication-title: Science – volume: 326 start-page: 1005 year: 2009 end-page: 1007 article-title: Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle publication-title: Science – volume: 3 start-page: 16 year: 1996 end-page: 32 article-title: Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation publication-title: Neurobiol Dis – volume: 6 start-page: 366 year: 1995 end-page: 369 article-title: History of depression as a risk factor for Alzheimer's disease publication-title: Epidemiology – volume: 3 start-page: 16 year: 1996 end-page: 32 article-title: Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation publication-title: Neurobiol Dis – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 15 start-page: 832 year: 2007 end-page: 838 article-title: The relationship between cerebrospinal fluid biomarkers and depression in elderly women publication-title: Am J Geriatr Psychiatry – volume: 60 start-page: 1304 year: 2006 end-page: 1305 article-title: The vascular depression hypothesis: 10 years later publication-title: Biol Psychiatry – volume: 8 start-page: 365 year: 2003 end-page: 370 article-title: Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors publication-title: Redox Rep – volume: 63 start-page: 153 year: 2006 end-page: 160 article-title: Depressive symptoms and cognitive decline in late life: a prospective epidemiological study publication-title: Arch Gen Psychiatry – volume: 67 start-page: 584 year: 2010 end-page: 587 article-title: Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly publication-title: Biol Psychiatry – volume: 57 start-page: 100 year: 2000 end-page: 105 article-title: Plasma and cerebrospinal fluid levels of amyloid beta proteins 1–40 and 1–42 in Alzheimer disease publication-title: Arch Neurol – volume: 22 start-page: 261 year: 2008 end-page: 268 article-title: Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B publication-title: Alzheimer Dis Assoc Disord – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 159 start-page: 1704 year: 2010 end-page: 1715 article-title: Soluble beta amyloid(1–42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? publication-title: Br J Psychopharmacol – volume: 176 start-page: 174 year: 2010 end-page: 178 article-title: Is there a CSF biomarker profile related to depression in elderly women? publication-title: Psychiatry Res – volume: 59 start-page: 512 year: 2006 end-page: 519 article-title: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans publication-title: Ann Neurol – volume: 18 start-page: 459 year: 2009 end-page: 469 article-title: Effects of stress and stress hormones on amyloid-beta protein and plaque deposition publication-title: J Alzheimers Dis – volume: 57 start-page: 100 year: 2000 end-page: 105 article-title: Plasma and cerebrospinal fluid levels of amyloid beta proteins 1–40 and 1–42 in Alzheimer disease publication-title: Arch Neurol – volume: 41 start-page: 1393 year: 1991 end-page: 1397 article-title: Clinical risk factors for Alzheimer's disease: a population-based case-control study publication-title: Neurology – volume: 159 start-page: 1704 year: 2010 end-page: 1715 article-title: Soluble beta amyloid(1–42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? publication-title: Br J Psychopharmacol – volume: 368 start-page: 387 year: 2006 end-page: 403 article-title: Alzheimer's disease publication-title: Lancet – volume: 64 start-page: 139 year: 2005 end-page: 146 article-title: Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque publication-title: J Neuropathol Exp Neurol – volume: 31 start-page: 341 year: 2006 end-page: 349 article-title: Elevation in plasma Abeta42 in geriatric depression: a pilot study publication-title: Neurochem Res – volume: 42 start-page: 894 year: 1985 end-page: 896 article-title: Depression in patients referred to a dementia clinic: a three-year prospective study publication-title: Arch Neurology – volume: 5 start-page: 228 year: 2006 end-page: 234 article-title: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study publication-title: Lancet Neurol – volume: 8 start-page: 365 year: 2003 end-page: 370 article-title: Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors publication-title: Redox Rep – volume: 8 start-page: 365 year: 2003 end-page: 370 article-title: Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors publication-title: Redox Rep – volume: 67 start-page: 584 year: 2010 end-page: 587 article-title: Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly publication-title: Biol Psychiatry – volume: 57 start-page: 100 year: 2000 end-page: 105 article-title: Plasma and cerebrospinal fluid levels of amyloid beta proteins 1–40 and 1–42 in Alzheimer disease publication-title: Arch Neurol – volume: 5 start-page: 228 year: 2006 end-page: 234 article-title: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study publication-title: Lancet Neurol – volume: 22 start-page: 536 year: 2007 end-page: 542 article-title: Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly publication-title: Int J Geriatr Psychiatry – volume: 31 start-page: 341 year: 2006 end-page: 349 article-title: Elevation in plasma Abeta42 in geriatric depression: a pilot study publication-title: Neurochem Res – volume: 35 start-page: S78 year: 2010 end-page: S187 article-title: Cortical beta-amyloid deposition in late-life depression publication-title: Neuropsychopharmacology – volume: 2 start-page: 357 year: 1984 end-page: 369 article-title: The amyloid deposits in Alzheimer's disease: their nature and pathogenesis publication-title: Appl Pathol – volume: 176 start-page: 174 year: 2010 end-page: 178 article-title: Is there a CSF biomarker profile related to depression in elderly women? publication-title: Psychiatry Res – volume: 17 start-page: 653 year: 2009 end-page: 656 article-title: Depressed mood is not a risk factor for incident dementia in a community-based cohort publication-title: Am J Geriatr Psychiatry – volume: 17 start-page: 653 year: 2009 end-page: 656 article-title: Depressed mood is not a risk factor for incident dementia in a community-based cohort publication-title: Am J Geriatr Psychiatry – volume: 176 start-page: 174 year: 2010 end-page: 178 article-title: Is there a CSF biomarker profile related to depression in elderly women? publication-title: Psychiatry Res – volume: 159 start-page: 1704 year: 2010 end-page: 1715 article-title: Soluble beta amyloid(1–42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? publication-title: Br J Psychopharmacol – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 156 start-page: 774 year: 2009 end-page: 785 article-title: Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor publication-title: Br J Clin Pharmacol – volume: 35 start-page: 776 year: 2001 end-page: 781 article-title: History of depression as a risk factor for dementia: an updated review publication-title: Aust NZ J Psychiatry – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 53 start-page: 1998 year: 1999 end-page: 2002 article-title: The occurrence of depressive symptoms in the preclinical phase of AD publication-title: Neurology – volume: 368 start-page: 387 year: 2006 end-page: 403 article-title: Alzheimer's disease publication-title: Lancet – volume: 67 start-page: 584 year: 2010 end-page: 587 article-title: Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly publication-title: Biol Psychiatry – volume: 326 start-page: 1005 year: 2009 end-page: 1007 article-title: Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle publication-title: Science – volume: 41 start-page: 1393 year: 1991 end-page: 1397 article-title: Clinical risk factors for Alzheimer's disease: a population-based case-control study publication-title: Neurology – volume: 22 start-page: 536 year: 2007 end-page: 542 article-title: Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly publication-title: Int J Geriatr Psychiatry – volume: 176 start-page: 174 year: 2010 end-page: 178 article-title: Is there a CSF biomarker profile related to depression in elderly women? publication-title: Psychiatry Res – volume: 368 start-page: 387 year: 2006 end-page: 403 article-title: Alzheimer's disease publication-title: Lancet – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 60 start-page: 753 year: 2003 end-page: 759 article-title: Depression as a risk factor for Alzheimer disease: the MIRAGE study publication-title: Arch Neurol – volume: 22 start-page: 536 year: 2007 end-page: 542 article-title: Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly publication-title: Int J Geriatr Psychiatry – volume: 59 start-page: 512 year: 2006 end-page: 519 article-title: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans publication-title: Ann Neurol – volume: 68 start-page: 1143 year: 2011 end-page: 1150 article-title: Protein binding in patients with late-life depression publication-title: Arch Gen Psychiatry – volume: 31 start-page: 341 year: 2006 end-page: 349 article-title: Elevation in plasma Abeta42 in geriatric depression: a pilot study publication-title: Neurochem Res – volume: 176 start-page: 174 year: 2010 end-page: 178 article-title: Is there a CSF biomarker profile related to depression in elderly women? publication-title: Psychiatry Res – volume: 14 start-page: 95 year: 2009 end-page: 105 article-title: The amyloidogenic potential and behavioral correlates of stress publication-title: Mol Psychiatry – volume: 22 start-page: 536 year: 2007 end-page: 542 article-title: Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly publication-title: Int J Geriatr Psychiatry – volume: 160 start-page: 376 year: 2003 end-page: 379 article-title: Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231 publication-title: Am J Psychiatry – volume: 159 start-page: 1704 year: 2010 end-page: 1715 article-title: Soluble beta amyloid(1–42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? publication-title: Br J Psychopharmacol – volume: 68 start-page: 1143 year: 2011 end-page: 1150 article-title: Protein binding in patients with late-life depression publication-title: Arch Gen Psychiatry – volume: 68 start-page: 1143 year: 2011 end-page: 1150 article-title: Protein binding in patients with late-life depression publication-title: Arch Gen Psychiatry – volume: 352 start-page: 67 year: 2003 end-page: 69 article-title: Cerebrospinal fluid markers for prediction of Alzheimer's disease publication-title: Neurosci Lett – volume: 22 start-page: 536 year: 2007 end-page: 542 article-title: Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly publication-title: Int J Geriatr Psychiatry – volume: 5 start-page: 228 year: 2006 end-page: 234 article-title: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study publication-title: Lancet Neurol – volume: 6 start-page: 366 year: 1995 end-page: 369 article-title: History of depression as a risk factor for Alzheimer's disease publication-title: Epidemiology – ident: B8 doi: 10.1097/JGP.0b013e3181aad1fe – ident: B31 doi: 10.1016/S1567-5688(02)00045-4 – ident: B1 doi: 10.1046/j.1440-1614.2001.00967.x – ident: B9 doi: 10.1001/archpsyc.63.2.153 – ident: B22 doi: 10.1007/s11064-005-9029-z – ident: B27 doi: 10.1038/npp.2010.216 – ident: B33 doi: 10.1179/135100003225003393 – ident: B37 doi: 10.1016/j.biopsych.2006.09.006 – ident: B14 doi: 10.1002/ana.20730 – ident: B16 doi: 10.1016/j.neulet.2003.08.011 – volume-title: Assessment of Aphasia and Related Disorders year: 1972 ident: B36 – ident: B19 doi: 10.1093/jnen/64.2.139 – ident: B20 doi: 10.1111/j.1476-5381.2010.00669.x – ident: B28 doi: 10.1001/archgenpsychiatry.2011.122 – ident: B29 doi: 10.1176/appi.ajp.160.2.376 – ident: B4 doi: 10.1097/00001648-199507000-00006 – ident: B5 doi: 10.1212/WNL.53.9.1998 – ident: B38 doi: 10.1126/science.1180962 – ident: B24 doi: 10.1097/JGP.0b013e3180547091 – ident: B40 doi: 10.1007/s00018-009-0055-x – ident: B7 doi: 10.1038/sj.npp.1300554 – ident: B17 doi: 10.1038/sj.mp.4002101 – ident: B18 doi: 10.3233/JAD-2009-1152 – ident: B25 doi: 10.1016/j.psychres.2008.11.012 – ident: B23 doi: 10.1001/archneur.57.1.100 – ident: B10 doi: 10.1016/S0140-6736(06)69113-7 – ident: B39 doi: 10.1016/j.biopsych.2009.08.024 – ident: B2 doi: 10.1212/WNL.41.9.1393 – ident: B3 doi: 10.1001/archneur.60.5.753 – ident: B15 doi: 10.1016/S1474-4422(06)70355-6 – ident: B13 doi: 10.1006/nbdi.1996.0003 – ident: B34 doi: 10.1111/j.2164-0947.1974.tb01606.x – volume: 2 start-page: 357 year: 1984 ident: B12 publication-title: Appl Pathol – ident: B21 doi: 10.1002/gps.1710 – ident: B26 doi: 10.1097/WAD.0b013e31816c92bf – ident: B30 doi: 10.1111/j.1476-5381.2008.00080.x – ident: B11 doi: 10.1016/j.exger.2009.08.002 – ident: B32 doi: 10.1080/1071576021000049890 – ident: B6 doi: 10.1001/archneur.1985.04060080080019 – reference: 12562590 - Am J Psychiatry. 2003 Feb;160(2):376-9 – reference: 12756140 - Arch Neurol. 2003 May;60(5):753-9 – reference: 18580591 - Alzheimer Dis Assoc Disord. 2008 Jul-Sep;22(3):261-8 – reference: 16461857 - Arch Gen Psychiatry. 2006 Feb;63(2):153-60 – reference: 7548342 - Epidemiology. 1995 Jul;6(4):366-9 – reference: 15354182 - Neuropsychopharmacology. 2004 Dec;29(12):2242-50 – reference: 17096467 - Int J Geriatr Psychiatry. 2007 Jun;22(6):536-42 – reference: 19521663 - Cell Mol Life Sci. 2009 Sep;66(18):2985-3008 – reference: 17911361 - Am J Geriatr Psychiatry. 2007 Oct;15(10):832-8 – reference: 12573364 - Atheroscler Suppl. 2002 Dec;3(4):57-68 – reference: 19220291 - Br J Pharmacol. 2009 Mar;156(5):774-85 – reference: 22065530 - Arch Gen Psychiatry. 2011 Nov;68(11):1143-50 – reference: 10634455 - Arch Neurol. 2000 Jan;57(1):100-5 – reference: 16876668 - Lancet. 2006 Jul 29;368(9533):387-403 – reference: 11990888 - Aust N Z J Psychiatry. 2001 Dec;35(6):776-81 – reference: 12607822 - Free Radic Res. 2002 Dec;36(12):1307-13 – reference: 19698775 - Exp Gerontol. 2010 Jan;45(1):23-9 – reference: 20132991 - Psychiatry Res. 2010 Apr 30;176(2-3):174-8 – reference: 19634208 - Am J Geriatr Psychiatry. 2009 Aug;17(8):653-63 – reference: 10599771 - Neurology. 1999 Dec 10;53(9):1998-2002 – reference: 15751228 - J Neuropathol Exp Neurol. 2005 Feb;64(2):139-46 – reference: 19779148 - Science. 2009 Nov 13;326(5955):1005-7 – reference: 19833321 - Biol Psychiatry. 2010 Mar 15;67(6):584-7 – reference: 4026634 - Arch Neurol. 1985 Sep;42(9):894-6 – reference: 20218978 - Br J Pharmacol. 2010 Apr;159(8):1704-15 – reference: 17912249 - Mol Psychiatry. 2009 Jan;14(1):95-105 – reference: 1891088 - Neurology. 1991 Sep;41(9):1393-7 – reference: 19584430 - J Alzheimers Dis. 2009;18(2):459-69 – reference: 9173910 - Neurobiol Dis. 1996 Feb;3(1):16-32 – reference: 14615052 - Neurosci Lett. 2003 Nov 27;352(1):67-9 – reference: 16583267 - Neurochem Res. 2006 Mar;31(3):341-9 – reference: 17157096 - Biol Psychiatry. 2006 Dec 15;60(12):1304-5 – reference: 6242724 - Appl Pathol. 1984;2(6):357-69 – reference: 16488378 - Lancet Neurol. 2006 Mar;5(3):228-34 – reference: 16372280 - Ann Neurol. 2006 Mar;59(3):512-9 – reference: 14980069 - Redox Rep. 2003;8(6):365-70 |
| SSID | ssj0000372 |
| Score | 2.4178905 |
| Snippet | Objective:Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional antidepressant treatment, especially in the... Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional antidepressant treatment, especially in the long... Objective: Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional antidepressant treatment, especially in... |
| SourceID | swepub pubmedcentral proquest pubmed pascalfrancis crossref appi |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 523 |
| SubjectTerms | Adult and adolescent clinical studies Aged Amyloid beta-Peptides Amyloid beta-Peptides - cerebrospinal fluid Biological and medical sciences Case-Control Studies cerebrospinal fluid Depression Depressive Disorder Depressive Disorder, Major - cerebrospinal fluid F2-Isoprostanes F2-Isoprostanes - cerebrospinal fluid Female Geriatric psychology Humans Major Male Medical sciences Mental depression Mood disorders Neuropsychological Tests Neuropsychology Neurosciences Neurovetenskaper Peptide Fragments Peptide Fragments - cerebrospinal fluid Peptides Psychiatric Status Rating Scales Psychology. Psychoanalysis. Psychiatry Psychopathology Psychopathology. Psychiatry Psychopharmacology tau Proteins tau Proteins - cerebrospinal fluid |
| Title | Lower CSF Amyloid Beta Peptides and Higher F2-Isoprostanes in Cognitively Intact Elderly Individuals With Major Depressive Disorder |
| URI | http://dx.doi.org/10.1176/appi.ajp.2011.11081153 https://www.ncbi.nlm.nih.gov/pubmed/22764362 https://www.proquest.com/docview/1020532189 https://www.proquest.com/docview/1024099476 https://pubmed.ncbi.nlm.nih.gov/PMC3586557 https://gup.ub.gu.se/publication/180650 |
| Volume | 169 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swELYYk6ZJ07SfrBtDnjTtpcto7MROHxmigg0YGkXiLXIdB4ogrWjzAK_7S_ef7M52mmSgse0lSu04cnWfz3fOd3eEvOeyb7KwL4Oc5TyITMwDxVQUKNgb8iTKEyMxGnlvX2wfRV-O4-OlpZ8N1lI5H33S17fGlfyPVKEN5IpRsv8g2cVLoQHuQb5wBQnD9a9kvIslzrqbh4PuxgU43uOs-9nMVfcAmSqZcdmXPZFjwIKd2WSKMR6qsCQsUAWeOXR-hQeDGCy5hTW77c8qTAv5sfPT7p46m1yCcnK0WSQb-aydTeN2WEepFM2UFG1GtVXEkwtlCxx198vi2lHB3KFAaUuBO6r9AnOHyCdW5z7Zgbmc1Ae22-4c3A76rq4uSrj3xG9_loGkkLjFC6mmeFDNa6xvwLRW5P3YlhKGbazS3ViZ18eaV8rdFYLxKI4bqjp2cc43txBpcydPMZTwbOqSvGKsBJjOvN40K6LA_rd0cLS7mw63joftXmsjMJEkoTVr75H7DDwZ6_XvfK2NBS5Z5aHh__FB7DCJ9dunAKYDdrTMqEdTNYMVnbtSLLf5Sjcpv63EuNaYGj4hj70XRDccpJ-SJVM8Iw_2PM_jOflhkU0B2dQjmyKyaYVsCiKnDtn0N2TTcUEbyKYO2dQjmzaQTRHZ1CKb1simFbJfkKPB1nBzO_DlQgIViT4PtMiV0nkiZaZ0FLGeFqHmUnI90hFnsYoylYWxSaBX5-D2c2gwQqqM94zojfhLslxMCvOKUCZD1edgqhupo5HIVC60xFyGIhOg2cIO-YhCSP1SmqXWlZYita0gsxRlllYy65C4Elaqfep9rABzfue49cW4qUs-c-eItRYWFsNYDJ5QksADqxU4mrNnWCAmTPod8m7RDfsMfjwE0U1K-0wE3mQkRYesOCzVL2cSHBvBOkS2ULZ4AHPYt3uK8anNZc9jjIyXHfLB4bE15KScptB0UqYzk4ZIAem9_vP835CHtV5ZJcvzy9K8Ba9hPlqz6-4XHhodVw |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lower+CSF+Amyloid+Beta+Peptides+and+Higher+F2-Isoprostanes+in+Cognitively+Intact+Elderly+Individuals+With+Major+Depressive+Disorder&rft.jtitle=The+American+journal+of+psychiatry&rft.au=Pomara%2C+Nunzio&rft.au=Bruno%2C+Davide&rft.au=Sarreal%2C+Antero+S&rft.au=Hernando%2C+Raymundo+T&rft.date=2012-05-01&rft.pub=American+Psychiatric+Association&rft.issn=0002-953X&rft.eissn=1535-7228&rft.volume=169&rft.issue=5&rft.spage=523&rft_id=info:doi/10.1176%2Fappi.ajp.2011.11081153&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=2688100851 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-953X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-953X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-953X&client=summon |